In the present study, we used leptin-receptor-deficient db/db mice, a mouse model of type 2 diabetes, to investigate the effect of EchA on DN progression and gain more insight into the mechanisms underlying the beneficial action of EchA in vivo. This evidence concerns the gene LEPR and liver dysplastic nodule.